US Stock MarketDetailed Quotes
IART Integra Lifesciences
- 21.558
- -0.002-0.01%
Trading Aug 19 11:25 ET
1.67BMarket Cap74.34P/E (TTM)
21.760High21.455Low154.04KVolume21.630Open21.560Pre Close3.33MTurnover0.23%Turnover Ratio25.66P/E (Static)77.58MShares45.42052wk High1.09P/B1.43BFloat Cap21.08052wk Low--Dividend TTM66.44MShs Float77.400Historical High--Div YieldTTM1.42%Amplitude1.500Historical Low21.590Avg Price1Lot Size
Integra Lifesciences Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.68%418.18M | -3.14%368.87M | -1.03%1.54B | -0.25%397.04M | -0.72%382.42M | -4.16%381.27M | 1.12%380.85M | 0.99%1.56B | -1.85%398.02M | -0.43%385.19M |
| Operating revenue | 9.68%418.18M | -3.14%368.87M | -1.03%1.54B | -0.25%397.04M | -0.72%382.42M | -4.16%381.27M | 1.12%380.85M | 0.99%1.56B | -1.85%398.02M | -0.43%385.19M |
| Cost of revenue | 10.34%192.26M | 9.50%162.04M | 11.83%656.84M | 15.28%170.55M | 10.53%164.08M | 17.41%174.24M | 3.79%147.98M | -1.75%587.36M | -5.32%147.94M | 2.75%148.45M |
| Gross profit | 9.12%225.92M | -11.18%206.83M | -8.82%884.74M | -9.43%226.49M | -7.77%218.35M | -16.99%207.03M | -0.51%232.87M | 2.72%970.31M | 0.33%250.09M | -2.33%236.75M |
| Operating expense | 17.70%228.95M | 3.25%202.87M | 5.72%773.21M | 4.50%190.45M | 11.68%191.75M | 2.63%194.52M | 4.57%196.49M | -2.14%731.39M | -4.61%182.25M | -7.67%171.7M |
| Selling and administrative expenses | 18.53%195.47M | -0.52%165.8M | 6.54%656.64M | 7.38%163.13M | 12.60%161.95M | 2.65%164.91M | 4.21%166.66M | -3.31%616.32M | -6.37%151.92M | -7.81%143.82M |
| Research and development costs | 11.96%29.77M | 0.90%26.97M | 2.96%104.19M | -9.33%24.28M | 7.52%26.6M | 3.90%26.59M | 10.96%26.72M | 8.75%101.19M | 8.32%26.78M | -4.24%24.74M |
| Depreciation amortization depletion | 22.50%3.71M | 225.19%10.11M | -10.85%12.38M | -14.37%3.03M | 2.13%3.21M | -8.41%3.03M | -20.18%3.11M | -17.93%13.88M | -13.08%3.54M | -23.63%3.14M |
| -Depreciation and amortization | 22.50%3.71M | 225.19%10.11M | -10.85%12.38M | -14.37%3.03M | 2.13%3.21M | -8.41%3.03M | -20.18%3.11M | -17.93%13.88M | -13.08%3.54M | -23.63%3.14M |
| Operating profit | -124.22%-3.03M | -89.10%3.96M | -53.32%111.53M | -46.86%36.05M | -59.12%26.59M | -79.11%12.5M | -21.19%36.38M | 21.14%238.92M | 16.52%67.84M | 15.26%65.05M |
| Net non-operating interest income expense | -59.45%-13.59M | -7.39%-8.58M | 9.29%-34.18M | -21.35%-9.2M | 11.42%-8.46M | 17.00%-8.53M | 22.23%-7.99M | 13.70%-37.68M | 29.04%-7.58M | 8.27%-9.55M |
| Non-operating interest income | 28.41%5.06M | 22.72%5.04M | 44.35%17.2M | -14.35%4.55M | 41.15%4.61M | 100.46%3.94M | 198.26%4.11M | 76.89%11.92M | 269.08%5.31M | 82.75%3.26M |
| Non-operating interest expense | 49.64%18.65M | 12.60%13.62M | 3.60%51.38M | 6.65%13.75M | 1.98%13.06M | 1.86%12.46M | 3.82%12.1M | -1.59%49.59M | 6.34%12.89M | 5.06%12.81M |
| Other net income (expense) | 1,027.10%1.44M | -143.92%-610K | -70.61%3.72M | -49.05%2.01M | -85.69%471K | -107.83%-155K | -59.49%1.39M | -79.30%12.65M | -7.04%3.95M | -30.77%3.29M |
| Special income (charges) | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -98.46%644K | --0 | 380.00%644K |
| -Gain on sale of business | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -98.46%644K | --0 | 380.00%644K |
| Other non- operating income (expenses) | 1,027.10%1.44M | -143.92%-610K | -69.03%3.72M | -49.05%2.01M | -82.21%471K | -107.83%-155K | -59.49%1.39M | -37.81%12.01M | -10.59%3.95M | -46.88%2.65M |
| Income before tax | -497.10%-15.19M | -117.56%-5.23M | -62.10%81.07M | -55.06%28.86M | -68.35%18.61M | -92.59%3.82M | -24.26%29.78M | -0.36%213.89M | 23.98%64.21M | 15.77%58.8M |
| Income tax | -673.06%-2.78M | -135.10%-1.95M | -60.03%13.33M | -19.87%9.02M | -110.00%-888K | -105.30%-360K | -13.44%5.55M | -26.88%33.34M | 75.89%11.26M | 17.49%8.88M |
| Net income | -396.41%-12.4M | -113.54%-3.28M | -62.48%67.74M | -62.54%19.83M | -60.94%19.5M | -90.66%4.18M | -26.37%24.23M | 6.79%180.55M | 16.66%52.95M | 15.47%49.92M |
| Net income continuous Operations | -396.41%-12.4M | -113.54%-3.28M | -62.48%67.74M | -62.54%19.83M | -60.94%19.5M | -90.66%4.18M | -26.37%24.23M | 6.79%180.55M | 16.66%52.95M | 15.47%49.92M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -396.41%-12.4M | -113.54%-3.28M | -62.48%67.74M | -62.54%19.83M | -60.94%19.5M | -90.66%4.18M | -26.37%24.23M | 6.79%180.55M | 16.66%52.95M | 15.47%49.92M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -396.41%-12.4M | -113.54%-3.28M | -62.48%67.74M | -62.54%19.83M | -60.94%19.5M | -90.66%4.18M | -26.37%24.23M | 6.79%180.55M | 16.66%52.95M | 15.47%49.92M |
| Basic earnings per share | -420.00%-0.16 | -113.33%-0.04 | -61.01%0.85 | -59.73%0.2537 | -60.00%0.24 | -90.74%0.05 | -23.08%0.3 | 9.00%2.18 | 17.58%0.63 | 17.65%0.6 |
| Diluted earnings per share | -420.00%-0.16 | -113.79%-0.04 | -61.11%0.84 | -60.32%0.25 | -60.00%0.24 | -90.74%0.05 | -25.64%0.29 | 9.09%2.16 | 18.87%0.63 | 17.65%0.6 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
